EPYSQLI DIN 02547740
Status: Approved
Holder: SAMSUNG BIOEPIS CO., LTD
Available to quote
Health Canada record
| Active ingredient(s) | ECULIZUMAB 10 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | PRESCRIPTION; SCHEDULE D |
|---|
| Class | Human |
|---|
| ATC | L04AJ01 ECULIZUMAB |
|---|
| Original market date | |
|---|
| Current status date | 17-Jun-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Samsung Bioepis Co., Ltd. — licence , not currently licensed, last inspection rating C (2023-04-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ECULIZUMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02322285 | SOLIRIS | ALEXION PHARMA GMBH | Solution | ECULIZUMAB 10 MG | Marketed |
| 02540509 | BEKEMV | AMGEN CANADA INC | Solution | ECULIZUMAB 10 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37727 | 2026-06-17 | New Drug Submission (NDS) | |
Request a quote for EPYSQLI
How to read a Canadian DIN record